M Sekimoto Selected Research

RNA (Ribonucleic Acid)

7/2001

Expression of second class of KIP protein p57KIP2 in human colorectal carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Sekimoto Research Topics

Disease

21	Neoplasms (Cancer) 05/2015 - 01/2000
14	Colorectal Neoplasms (Colorectal Cancer) 11/2009 - 02/2000
5	Neoplasm Metastasis (Metastasis) 12/2020 - 01/2000
5	Neoplasm Micrometastasis 11/2005 - 05/2001
4	Colonic Neoplasms (Colon Cancer) 03/2007 - 01/2000
3	Carcinogenesis 10/2006 - 08/2001
3	Stomach Neoplasms (Stomach Cancer) 01/2004 - 02/2000
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2020 - 01/2001
2	Breast Neoplasms (Breast Cancer) 12/2001 - 05/2001
2	Lymphatic Metastasis 06/2001 - 05/2001
2	Sleep Wake Disorders 04/2001 - 02/2000
2	Circadian Rhythm Sleep Disorders (Delayed Sleep Phase Syndrome) 06/2000 - 02/2000
1	Peritoneal Neoplasms 12/2020
1	Adenomatous Polyps 10/2006
1	Microsatellite Instability 09/2006
1	Vomiting 12/2005
1	Nausea 12/2005
1	Esophageal Neoplasms (Esophageal Cancer) 08/2003
1	Margins of Excision 12/2001
1	Ventricular Fibrillation 08/2001
1	Out-of-Hospital Cardiac Arrest 08/2001
1	Disease Progression 06/2001
1	Meningeal Tuberculosis (Tuberculous Meningitis) 04/2001
1	Tuberculosis (Tuberculoses) 04/2001
1	Contusions 09/2000
1	Massive Hepatic Necrosis 07/2000
1	Hepatitis 07/2000
1	Carcinoma (Carcinomatosis) 02/2000
1	Melanoma (Melanoma, Malignant) 01/2000

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 11/2009 - 02/2000
3	Messenger RNA (mRNA)IBA 09/2000 - 02/2000
3	alpha-galactosylceramideIBA 07/2000 - 01/2000
2	Complementary DNA (cDNA)IBA 09/2004 - 08/2001
2	Genetic Markers (Genetic Marker)IBA 09/2001 - 05/2001
2	Therapeutic UsesIBA 09/2001 - 01/2000
2	cdc25 PhosphatasesIBA 09/2001 - 06/2000
2	CytokinesIBA 05/2001 - 01/2000
2	Carcinoembryonic AntigenIBA 05/2001 - 02/2000
2	Cytosine DeaminaseIBA 05/2001 - 01/2001
2	DNA (Deoxyribonucleic Acid)IBA 04/2001 - 02/2000
2	LigandsIBA 01/2000 - 01/2000
2	Interleukin-12 (IL 12)IBA 01/2000 - 01/2000
1	130-nm albumin-bound paclitaxelIBA 12/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2020
1	Gemcitabine FDA Link 12/2020
1	Biological ProductsIBA 11/2009
1	VimentinIBA 03/2007
1	PPAR deltaIBA 10/2006
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2006
1	Transforming Growth Factor-beta Type II ReceptorIBA 09/2006
1	Transforming Growth Factor beta (TGF-beta)IBA 09/2006
1	Granisetron (Kytril)FDA LinkGeneric 12/2005
1	Irinotecan (Camptosar)FDA LinkGeneric 12/2005
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 12/2005
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2005
1	Calcibiotic Root Canal SealerIBA 09/2004
1	Keratins (Keratin)IBA 09/2001
1	Tumor Biomarkers (Tumor Markers)IBA 09/2001
1	Cyclin-Dependent Kinase Inhibitor p57IBA 07/2001
1	RNA (Ribonucleic Acid)IBA 07/2001
1	Keratin-20 (Cytokeratin 20)IBA 05/2001
1	Estrogen ReceptorsIBA 05/2001
1	Cadherins (E-Cadherin)IBA 05/2001
1	Mammaglobin AIBA 05/2001
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2001
1	BCG Vaccine FDA Link 04/2001
1	VaccinesIBA 04/2001
1	EnzymesIBA 01/2001
1	Cyclin D1IBA 01/2001
1	Liposomes (Liposome)IBA 01/2001
1	beta CateninIBA 01/2001
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 07/2000
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2000
1	Fibrinogen (Factor I)FDA Link 03/2000
1	Pyrimidine PhosphorylasesIBA 03/2000
1	Fluorouracil (Carac)FDA LinkGeneric 03/2000
1	doxifluridineIBA 03/2000
1	PicibanilIBA 03/2000
1	MT2 Melatonin ReceptorIBA 02/2000
1	Cyclin-Dependent Kinase Inhibitor p27IBA 02/2000
1	Indicators and Reagents (Reagents)IBA 02/2000
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 02/2000
1	Interleukin-4 (Interleukin 4)IBA 01/2000
1	InterleukinsIBA 01/2000
1	AntigensIBA 01/2000

Therapy/Procedure

7	Therapeutics 10/2001 - 01/2000
4	Drug Therapy (Chemotherapy) 12/2020 - 03/2000
3	Lymph Node Excision (Lymph Node Dissection) 05/2015 - 01/2004
2	Immunotherapy 03/2000 - 01/2000
1	Chemoprevention 10/2006
1	Operative Surgical Procedures 08/2003
1	Esophagectomy 08/2003
1	Sternotomy 08/2003
1	Endoscopes 12/2001
1	Segmental Mastectomy (Lumpectomy) 12/2001
1	Cardiopulmonary Resuscitation (CPR) 08/2001
1	Laparotomy 09/2000
1	Neoadjuvant Therapy 09/2000
1	Phototherapy (Light Therapy) 06/2000
1	Subcutaneous Injections 01/2000